RE: Beijiing Cancer Hospital Write up28 Feb 2025 16:30
He says phase 1b started, or does he?
The good efficacy and safety data shown in the Phase Ia trial support the initiation of three expansion cohorts in the Phase Ib trial (including cohorts of patients with triple-negative breast cancer , soft tissue sarcoma , and salivary gland cancer, who will receive AVA6000 treatment in the first and second lines).